NURS 5432 – Test 1 Materials (2025–2026), Questionbank &
Testbank Study Guide with Verified A+ Solutions –
Comprehensive Exam Preparation Summary
Introduction:
This document provides a complete and structured overview of Test 1
content for NURS 5432, including contraceptive pharmacology,
menopause management, osteoporosis screening, pregnancy care,
pediatrics, growth and development, vaccines, STIs, reproductive
disorders, urology, and key diagnostic/therapeutic guidelines. It
contains question-and-answer style material, definitions, clinical
pearls, and exam-focused facts verified for accuracy. The study guide
covers obstetrics, gynecology, family practice, pediatrics,
endocrinology, pharmacology, and men's health, making it a full
exam-aligned resource.
Exam Questions and Answers
Biphasic --- correct precise answer ---Dose changes midway
through the cycle.
Triphasic --- correct precise answer ---Dose may change weekly.
LARC --- correct precise answer ---Long-acting reversible
contraception options.
Contraindications for estrogen --- correct precise answer ---Include
history of blood clots, CAD, and certain cancers.
,Menopause --- correct precise answer ---Defined as 12 months of
amenorrhea in women over 40.
Z < 2.5 SD --- correct precise answer ---Confirms osteoporosis
Risks for osteoporosis --- correct precise answer ---Include history
of fractures, low body weight, cigarette smoking, and family history
of osteoporotic fractures
Hormone Replacement Therapy (HRT) goal --- correct precise
answer ---Minimize moderate to severe vasomotor symptoms
Estrogen + progesterone (HRT) in women without hysterectomy ---
correct precise answer ---To prevent endometrial hyperplasia (EH)
or endometrial cancer (EC)
Estrogen only (ERT) in women with hysterectomy --- correct
precise answer ---Progesterone is not needed as prevention of
endometrial hyperplasia is no longer relevant
Non-hormonal medications for menopause --- correct precise
answer ---Second-line treatment with a brief period of efficacy,
,including Paroxetine, Venlafaxine, Fluoxetine, Citalopram,
Gabapentin, and Clonidine
Safety of hormone therapy --- correct precise answer ---Safe only
in short-term use; long-term use increases the risk of
cardiovascular disease, cancer, and venous thromboembolism
Absolute contraindications for hormone replacement therapy ---
correct precise answer ---Estrogen-dependent malignancies,
unexplained uterine bleeding, history of venous thromboembolism
or cerebrovascular accident, coronary artery disease, active liver
disease
Genitourinary Syndrome --- correct precise answer ---
Vulvar/vaginal atrophy treated with topical estrogen therapy to
reverse vaginal atrophy, enhance blood flow, and reduce urinary
tract infections
Ospemifene 60mg PO qd --- correct precise answer ---Selective
estrogen receptor modulator (SERM) for moderate to severe
dyspareunia
Estrogen and progesterone use --- correct precise answer ---Based
on whether the patient has had a hysterectomy
, Fibroadenoma --- correct precise answer ---Benign breast tumor
classified as simple or complex, with specific characteristics like
cysts, sclerosing adenosis, epithelial calcifications, and papillary
changes
Fibrocystic Breast Disease --- correct precise answer ---Spectrum of
breast tissue conditions common in premenopausal women,
managed with cold compresses, dietary adjustments, and imaging
to rule out malignancy
Nipple Discharge --- correct precise answer ---Can be benign,
unilateral or bilateral, with various causes including ductal ectasia,
papilloma, physiologic galactorrhea, and medication side effects
Breast Cancer Screening --- correct precise answer ---Dependent on
risk factors, with recommendations for mammograms and specific
medications for estrogen receptor-positive cancers
Benign Ovarian Tumor --- correct precise answer ---Nonmalignant
ovarian growths that can be solid or cystic, with oral contraceptives
decreasing the risk of malignancy
Ovarian Cancer --- correct precise answer ---Associated with
genetic factors like BRCA mutations, Lynch syndrome, and various
risk factors, diagnosed through imaging and tumor markers
Testbank Study Guide with Verified A+ Solutions –
Comprehensive Exam Preparation Summary
Introduction:
This document provides a complete and structured overview of Test 1
content for NURS 5432, including contraceptive pharmacology,
menopause management, osteoporosis screening, pregnancy care,
pediatrics, growth and development, vaccines, STIs, reproductive
disorders, urology, and key diagnostic/therapeutic guidelines. It
contains question-and-answer style material, definitions, clinical
pearls, and exam-focused facts verified for accuracy. The study guide
covers obstetrics, gynecology, family practice, pediatrics,
endocrinology, pharmacology, and men's health, making it a full
exam-aligned resource.
Exam Questions and Answers
Biphasic --- correct precise answer ---Dose changes midway
through the cycle.
Triphasic --- correct precise answer ---Dose may change weekly.
LARC --- correct precise answer ---Long-acting reversible
contraception options.
Contraindications for estrogen --- correct precise answer ---Include
history of blood clots, CAD, and certain cancers.
,Menopause --- correct precise answer ---Defined as 12 months of
amenorrhea in women over 40.
Z < 2.5 SD --- correct precise answer ---Confirms osteoporosis
Risks for osteoporosis --- correct precise answer ---Include history
of fractures, low body weight, cigarette smoking, and family history
of osteoporotic fractures
Hormone Replacement Therapy (HRT) goal --- correct precise
answer ---Minimize moderate to severe vasomotor symptoms
Estrogen + progesterone (HRT) in women without hysterectomy ---
correct precise answer ---To prevent endometrial hyperplasia (EH)
or endometrial cancer (EC)
Estrogen only (ERT) in women with hysterectomy --- correct
precise answer ---Progesterone is not needed as prevention of
endometrial hyperplasia is no longer relevant
Non-hormonal medications for menopause --- correct precise
answer ---Second-line treatment with a brief period of efficacy,
,including Paroxetine, Venlafaxine, Fluoxetine, Citalopram,
Gabapentin, and Clonidine
Safety of hormone therapy --- correct precise answer ---Safe only
in short-term use; long-term use increases the risk of
cardiovascular disease, cancer, and venous thromboembolism
Absolute contraindications for hormone replacement therapy ---
correct precise answer ---Estrogen-dependent malignancies,
unexplained uterine bleeding, history of venous thromboembolism
or cerebrovascular accident, coronary artery disease, active liver
disease
Genitourinary Syndrome --- correct precise answer ---
Vulvar/vaginal atrophy treated with topical estrogen therapy to
reverse vaginal atrophy, enhance blood flow, and reduce urinary
tract infections
Ospemifene 60mg PO qd --- correct precise answer ---Selective
estrogen receptor modulator (SERM) for moderate to severe
dyspareunia
Estrogen and progesterone use --- correct precise answer ---Based
on whether the patient has had a hysterectomy
, Fibroadenoma --- correct precise answer ---Benign breast tumor
classified as simple or complex, with specific characteristics like
cysts, sclerosing adenosis, epithelial calcifications, and papillary
changes
Fibrocystic Breast Disease --- correct precise answer ---Spectrum of
breast tissue conditions common in premenopausal women,
managed with cold compresses, dietary adjustments, and imaging
to rule out malignancy
Nipple Discharge --- correct precise answer ---Can be benign,
unilateral or bilateral, with various causes including ductal ectasia,
papilloma, physiologic galactorrhea, and medication side effects
Breast Cancer Screening --- correct precise answer ---Dependent on
risk factors, with recommendations for mammograms and specific
medications for estrogen receptor-positive cancers
Benign Ovarian Tumor --- correct precise answer ---Nonmalignant
ovarian growths that can be solid or cystic, with oral contraceptives
decreasing the risk of malignancy
Ovarian Cancer --- correct precise answer ---Associated with
genetic factors like BRCA mutations, Lynch syndrome, and various
risk factors, diagnosed through imaging and tumor markers
